We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+4.17%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$42.9B
AUM Growth
+$1.2B
Cap. Flow
-$23.9M
Cap. Flow %
-0.06%
Top 10 Hldgs %
13.77%
Holding
3,246
New
450
Increased
1,273
Reduced
1,008
Closed
492

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$276M
2
IBM icon
IBM
IBM
+$272M
3
PG icon
Procter & Gamble
PG
+$161M
4
CL icon
Colgate-Palmolive
CL
+$151M
5
BBBY
Bed Bath & Beyond Inc
BBBY
+$146M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$405M
2
CELG
Celgene Corp
CELG
+$207M
3
BKNG icon
Booking.com
BKNG
+$123M
4
LLY icon
Eli Lilly
LLY
+$114M
5
BEAM
BEAM INC COM STK (DE)
BEAM
+$109M

Sector Composition

Rank Sector Weight
1 Technology 16.85%
2 Healthcare 13.92%
3 Consumer Discretionary 12.37%
4 Industrials 10.61%
5 Consumer Staples 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCTC
2151
Jewett-Cameron Trading
JCTC
$10.3M
$772K ﹤0.01%
154,200
+2,200
+1% +$11.2K
DAIO icon
2152
Data I/O
DAIO
$30.8M
$768K ﹤0.01%
255,000
+9,900
+4% +$26.6K
ALO
2153
DELISTED
Alio Gold Inc
ALO
$767K ﹤0.01%
43,510
+18,570
+74% +$269K
SIF icon
2154
SIFCO Industries
SIF
$124M
$761K ﹤0.01%
24,400
+1,400
+6% +$46.5K
MDR
2155
DELISTED
McDermott International
MDR
$759K ﹤0.01%
31,267
-105,283
-77% -$2.31M
DNDN
2156
DELISTED
DENDREON CORPORATION
DNDN
$753K ﹤0.01%
+327,200
New +$767K
PWRD
2157
DELISTED
PERFECT WORLD CO LTD SPONSORED ADR REPSTG CL B (CAYMAN ISL)
PWRD
$750K ﹤0.01%
38,200
-40,300
-51% -$749K
CPRT icon
2158
Copart
CPRT
$27.2B
$748K ﹤0.01%
166,400
-651,552
-80% -$2.94M
SIFI
2159
DELISTED
SI Financial Group, Inc. NEW MD
SIFI
$748K ﹤0.01%
64,944
+4,296
+7% +$49.3K
MNRK
2160
DELISTED
MONARCH FINANCIAL HOLDINGS INC COM STK
MNRK
$747K ﹤0.01%
70,128
+8,638
+14% +$90.7K
PKT
2161
DELISTED
PROCERA NETWORKS INC NEW COM STK (DE)
PKT
$746K ﹤0.01%
73,930
+14,541
+24% +$138K
CSCI
2162
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$745K ﹤0.01%
64
+60
+1,500% +$670K
MG icon
2163
Mistras Group
MG
$556M
$741K ﹤0.01%
30,200
-57,600
-66% -$1.32M
PGR icon
2164
Progressive
PGR
$121B
$741K ﹤0.01%
29,200
-529,034
-95% -$13.1M
BFYT
2165
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$740K ﹤0.01%
60,032
+34,943
+139% +$360K
ASRV icon
2166
AmeriServ Financial
ASRV
$84.3M
$738K ﹤0.01%
212,000
+811
+0.4% +$2.88K
EWZ icon
2167
iShares MSCI Brazil ETF
EWZ
$8.55B
$736K ﹤0.01%
15,400
-254,800
-94% -$12.2M
FBRC
2168
DELISTED
FBR & Co. Common Stock
FBRC
$736K ﹤0.01%
27,123
-19,178
-41% -$504K
AEGN
2169
DELISTED
Aegion Corp
AEGN
$733K ﹤0.01%
+31,496
New +$748K
EWJ icon
2170
iShares MSCI Japan ETF
EWJ
$23.2B
$732K ﹤0.01%
15,200
-28,850
-65% -$1.32M
NATL
2171
DELISTED
National Interstate Corporation
NATL
$731K ﹤0.01%
+26,100
New +$735K
CO
2172
DELISTED
Global Cord Blood Corporation
CO
$728K ﹤0.01%
131,800
-2,700
-2% -$12.1K
DFT
2173
DELISTED
DuPont Fabros Technology Inc.
DFT
$728K ﹤0.01%
+27,000
New +$683K
EROC
2174
DELISTED
EAGLE ROCK ENERGY PARTNERS, L.P. COM UNITS RPTNG LTD PRTNR
EROC
$723K ﹤0.01%
+145,217
New +$664K
CRAI icon
2175
CRA International
CRAI
$1.07B
$722K ﹤0.01%
31,331
+21,759
+227% +$471K

Similar funds

Jim Simons's Q2 2014 Portfolio in Review

As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
  • Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
  • Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
  • Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
  • Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
  • Jim Simons opened 450 new positions and closed 492 in Q2 2014.
  • Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.

Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.